Crolom and Xanthoma - a phase IV clinical study of FDA data
We study 432 people who take Crolom or have Xanthoma. No report of Xanthoma is found in people who take Crolom.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Crolom?
Crolom has active ingredients of cromolyn sodium. eHealthMe is studying from 32 Crolom users for its effectiveness, alternative drugs and more.
What is Xanthoma?
Xanthoma (deposition of yellowish cholesterol in skin) is found to be associated with 371 drugs and 276 conditions by eHealthMe.
Do you take Crolom and have Xanthoma?Check whether Xanthoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Xanthoma and when was it recovered:
Expand to all the drugs that have ingredients of cromolyn sodium:
Alternative drugs to, pros and cons of Crolom:
- Crolom (32 reports)
Xanthoma treatments and more:
- Xanthoma (400 reports)
COVID vaccines that are related to Xanthoma:
- Xanthoma in Moderna COVID Vaccine
- Xanthoma in Pfizer BioNTech Covid Vaccine
- Xanthoma in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Xanthoma:
All the conditions that are associated with Xanthoma:
How the study uses the data?
The study uses data from the FDA. It is based on cromolyn sodium (the active ingredients of Crolom) and Crolom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Augmentin and Kenalog drug interaction - a second ago
- Amlodipine and Keratomileusis - 14 seconds ago
- Altace and Abdominal Discomfort - 16 seconds ago
- Valsartan and Xenical drug interaction - 37 seconds ago
- Nexavar and Cardiac Failure Acute - 38 seconds ago
- Aprepitant and Systemic Lupus Erythematosus - 39 seconds ago
- Campath and Muscle Atrophy - 53 seconds ago
- Minivelle and Zofran drug interaction - 56 seconds ago
- Meloxicam and Nuchal Rigidity - 56 seconds ago
- Metformin and Vitamin B drug interaction - a minute ago